Myrna C. Godoy

Myrna C. Godoy is a Senior Professor at The University of Texas MD Anderson Cancer Center. Her research focuses on thoracic oncology, lung cancer screening, and medical imaging, with particular emphasis on radiomics for dynamic lung cancer risk prediction and the application of the Brock and Sybil models to persistent pulmonary nodules. She has recently contributed to studies on SARS-CoV-2 mRNA vaccines sensitizing tumors to immune checkpoint blockade, published in *Nature*, and smoking cessation interventions in lung cancer screening settings, published in *JAMA Internal Medicine*. Her work also includes the Lung-RADS v2022 update and the IMPRINT-Lung phase II trial of pembrolizumab for interception of high-risk lung nodules.